HongRi pharmaceutical company's first imitative drug for the treatment of venous thromboembolism
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
PTS injection, a new anticancer drug of HongRi pharmaceutical, is still in the stage of production approval and is progressing smoothly We expect that it will be approved and marketed in 2014 The sulfondagangui sodium injection (GSK, the original manufacturer, is better than enoxaparin, and HongRi pharmaceutical industry will be the first imitator in China) for prevention and treatment of venous thromboembolism will be approved for production in 2014, and is expected to be approved for sale in 2015 Tianjin HongRi Pharmaceutical Co., Ltd is a joint stock limited company initiated by the overall change of Tianjin Datong HongRi Pharmaceutical Co., Ltd on the basis of the net assets audited by Tianjin Jinyuan certified public accountants Co., Ltd on August 31, 2000, and approved by the reply of Tianjin People's Government on Approving the change of Tianjin Datong HongRi Pharmaceutical Co., Ltd to Tianjin HongRi Pharmaceutical Co., Ltd The company is located in the west of Quanfa Road, Wuqing Development Zone, Tianjin, covering an area of 40000 square meters It has a production workshop and production line with multiple varieties and dosage forms of pharmaceutical raw materials, injection, oral preparations, etc The company's overall environment is elegant and the equipment is advanced The production workshops of all dosage forms have passed GMP certification.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
